Novartis Backs Off From 2016 Date for Testing Google Autofocus Lens

ZURICH – Novartis has abandoned a 2016 goal to start testing its autofocus contact lens on people, though it said the groundbreaking product it is making with internet giant Google┬áis “progressing steadily.” “It is too early to say when exactly human clinical trials for these lenses will begin,” a spokeswoman for the Basel-based drugmaker said

[ Read More ]

New Heart Drugs Struggle to Win Sales as Doctors Hold Back

By Ben Hirschler LONDON, April 21- New heart drugs hailed as breakthrough treatments by researchers are struggling to gain traction among prescribing doctors, posing a headache for makers such as Novartis, which reported more weak sales for its Entresto medicine on Thursday. Novartis has touted the novel heart failure drug as a $5 billion-a-year seller

[ Read More ]